Clinical Practice Guideline: Safe Medication Use in the ICU.

Area of Science:

• Critical Care Medicine
• Patient Safety
• Pharmacology

Background:

• Medication use in intensive care units (ICUs) presents unique challenges and risks for critically ill patients.
• Medication errors and adverse drug events (ADEs) are significant concerns in the ICU setting.
• Existing guidelines may not fully address the specific complexities of medication safety in critical care.

Purpose of the Study:

• To provide ICU clinicians with evidence-based guidance on safe medication use practices.
• To identify and evaluate environmental factors contributing to medication-related events in the ICU.
• To review prevention strategies across the medication use process and enhance patient safety surveillance.

Main Methods:

• A comprehensive literature search was conducted across multiple databases (PubMed, Cochrane, CINAHL, Scopus, Web of Science) up to December 2015.
• The committee developed Population, Intervention, Comparator, Outcome (PICO) questions and quality of evidence statements focusing on medication errors and ADEs.
• The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used to determine the quality of evidence and strength of recommendations.

Main Results:

• The guideline evaluates the ICU environment as a risk factor for medication-related events.
• Prevention strategies are reviewed for prescribing, distribution, administration, and monitoring phases of medication use.
• Considerations for an active surveillance system, including reporting, identification, and evaluation of events, are discussed.

Conclusions:

• The guideline provides actionable recommendations for improving safe medication use in the ICU.
• Environmental modifications and robust surveillance systems are crucial for mitigating medication-related risks.
• Further research is needed to develop medication safety practices specifically tailored for critically ill populations.